Abstract
Depression and anxiety are common among HIV-infected people and rank among the strongest predictors of non-adherence to antiretroviral therapy (ART). This longitudinal study aimed to assess whether symptoms of anxiety and depression are predictors of non-adherence among patients initiating ART at two public referral centers (n = 293) in Belo Horizonte, Brazil. Prevalence of severe anxiety and depression symptoms before starting ART was 12.6% and 5.8%, respectively. Severe anxiety was a predictor of non-adherence to ART during follow-up period (RH = 1.87; 95% CI = 1.14–3.06) adjusted for low education, unemployment, alcohol use in the last month and symptoms of AIDS; while a history of injection drug use had borderline statistical significance with non-adherence. These findings suggest that using a brief screening procedure to assess anxiety and depression symptoms before initiating ART help identify individuals for interventions to improve adherence and quality of life.
Similar content being viewed by others
References
Acurcio, F. A., Puig-Junoy, J., Bonolo, P. F., Ceccato, M. G. B., & Guimarães, M. D. C. (2006). Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil. Revista Espanola de Salud Publica, 80, 41–54. doi:10.1590/S1135-57272006000100005.
Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. doi:10.1176/appi.psy.45.5.394.
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2002). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423. doi:10.1086/323201.
Au, A., Chan, I., Li, P., Chung, R., Po, L. M., & Yu, P. (2004). Stress and health-related quality of life among HIV-infected persons in Hong Kong. AIDS and Behavior, 8, 119–129. doi:10.1023/B:AIBE.0000030243.50415.c0.
Barfod, T. S., Gerstoft, J., Rodkjaer, L., Pedersen, C., Nielsen, H., Moller, A., et al. (2005). Patient’s answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: A cross-sectional survey. AIDS Patient Care and STDs, 19, 317–325. doi:10.1089/apc.2005.19.317.
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An update literature review. Journal of Psychosomatic Research, 52, 69–77. doi:10.1016/S0022-3999(01)00296-3.
Blanco, J. M. S., Pérez, I. R., Lima, A. O. L., Recio, J. M. C., López, E. G., & Lasanta, J. J. A. (2005). Adherent to antiretroviral treatment in prisons. AIDS Research and Human Retroviruses, 21, 683–688. doi:10.1089/aid.2005.21.683.
Bonolo, P. F., César, C. C., Acúrcio, F. A., Ceccato, M. G. B., Pádua, C. A. M., Álvares, J., et al. (2005). Non-adherence among patients initiating antiretroviral therapy: A challenge for health professionals in Brazil. AIDS (London, England), 19, S5–S13. doi:10.1097/01.aids.0000191484.84661.2b.
Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., & Pereira, W. A. B. (1995). Mood disorders among medical in-patients: A validation study of the hospital anxiety and depression scale (HAD). Journal of Public Health, 29, 355–363.
Botega, N. J., Pondé, M. P., Medeiros, P., Lima, M. G., & Guerreiro, C. A. M. (1998). Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. Jornal Brasileiro de Psiquiatria, 47, 285–289.
Braithwaite, R. S., Mcginnis, K. A., Conigliaro, J., Maisto, S. A., Crystal, S., Day, N., et al. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism, Clinical and Experimental Research, 29, 1190–1197. doi:10.1097/01.ALC.0000171937.87731.28.
Brasil, Ministério da Saúde. (2000). Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV. Brasília: Ministério da Saúde.
Brasil, Ministério da Saúde. (2008). UNGASS. Resposta brasileira 2005/2007. Relatório de progresso do país. Brasília: Ministério da Saúde.
Campos, L. N., Bonolo, P. F., & Guimarães, M. D. C. (2006). Anxiety and depression assessment prior to initiating antiretroviral treatment in Brazil. AIDS Care, 18, 529–536. doi:10.1080/09540120500221704.
Carballo, E., Cadarso-Suárez, C., Carrera, I., Fraga, J., De La Fuente, J., Ocampo, A., et al. (2004). Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research, 13, 587–599. doi:10.1023/B:QURE.0000021315.93360.8b.
Carrieri, M. P., Raffi, F., Lewden, C., Sobel, A., Michelet, C., Cailleton, V., et al. (2003). Impact of early versus late-adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year follow-up study. Antiviral Therapy, 8, 585–594.
Carvalho, C. V., Duarte, D. B., Merchán-Hamann, E., Bicudo, E., & Laguardia, J. (2003). Predictors of compliance with highly active antiretroviral therapy in Brasília, Distrito Federal, Brazil, 1999–2000. Reports in Public Health, 19, 593–604.
Centers for Disease Control and Prevention. (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR, 41(RR-17), 1–19.
Chesney, M. (2004). Adherence to HAART regimens. In J. Laurence (Ed.), Medication adherence in HIV/AIDS (pp. 17–25). Larchmont: Mary Ann Liebert.
Cohen, M., Hoffman, R. G., Cromwell, C., Schmeidler, J., Ebrahim, F., Carrera, G., et al. (2002). The prevalence of distress in persons with Human Immunodeficiency Virus infection. Psychosomatics, 43, 10–15. doi:10.1176/appi.psy.43.1.10.
Cook, R. L., Sereika, S. M., Hunt, S. C., et al. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83–88. doi:10.1111/j.1525-1497.2001.00122.x.
Cove, J., & Petrak, J. (2004). Factors associated with sexual problems in HIV-positive gay men. International Journal of STD & AIDS, 15, 732–736. doi:10.1258/0956462042395221.
Cox, D. R., & Oakes, D. (1984). Analysis of survival data. New York: Chapman and Hall.
Crawford, J. R., Henry, J. D., Crombie, C., & Taylor, E. P. (2001). Brief report. Normative data for the HADS from a large non-clinical sample. The British Journal of Clinical Psychology, 40, 429–434. doi:10.1348/014466501163904.
Evans, D. L., Ten Have, T. R., Douglas, S. D., Gettes, D. R., Morrison, M., Chiappini, M. S., et al. (2002). Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. The American Journal of Psychiatry, 159, 752–759. doi:10.1176/appi.ajp. 159.10.1752.
Falagas, M. E., Zarkadoulia, E. A., Pliatsika, P. A., & Panos, G. (2008). Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: A systematic review of the literature. Retroviroloy, 5, 13. doi:10.1186/1742-4690-5-13.
Ford, J. D., Trestman, R. L., Steiberg, K., Tennen, H., & Allen, S. (2004). Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Social Science and Medicine, 58, 2145–2148. doi:10.1016/j.socscimed.2003.08.017.
Freitas, G. V. S., & Botega, N. J. (2002). Gravidez na adolescência: prevalência de depressão, ansiedade e ideação suicida. Revista da Associação Médica Brasileira, 48, 245–249.
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386–395.
Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS (London, England), 13, 1099–1107. doi:10.1097/00002030-199906180-00014.
Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41. doi:10.1016/S0022-3999(96)00216-4.
Hosmer, D. W., & Lemeshow, S. (1999). Applied survival analysis: Regression modeling of time to event data. New York: Wiley.
Lambert, S., Keegan, A., & Petrak, J. (2005). Sex and relationships for HIV positive women since HAART: A quantitative study. Sexually Transmitted Infections, 81, 333–337. doi:10.1136/sti.2004.013516.
Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (London, England), 16, 767–774. doi:10.1097/00002030-200203290-00012.
Mantel, N. (1963). Chi-square tests with one degree of freedom: Extensions of the Mantel–Haenszel procedure. Journal of the American Statistical Association, 58, 690–700. doi:10.2307/2282717.
Mendes, M. F., Tilbery, C. P., Balsimelli, S., Moreira, M. A., & Barão-Cruz, A. M. (2003). Depressão na esclerose múltipla forma remitente-recorrente. Arquivos de Neuro-Psiquiatria, 61, 591–595. doi:10.1590/S0004-282X2003000400012.
Melo, A. P. S., & Guimarães, M. D. C. (2005). Factors associated with psychiatric treatment dropout in a mental health reference center, Belo Horizonte. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999), 27, 113–118. doi:10.1590/S1516-44462005000200008.
Miller, N. H. (1997). Compliance with treatment regimens in chronic asymptomatic diseases. The American Journal of Medicine, 102, 4–49. doi:10.1016/S0002-9343(97)00467-1.
Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., & Lau, T. F. J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD and AIDS, 13, 301–310. doi:10.1258/0956462021925117.
Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported non-adherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123–128.
Nemes, M. I. B., Carvalho, H. B., & Souza, M. F. M. (2004). Antiretroviral therapy adherence in Brazil. AIDS (London, England), 18, S15–S20. doi:10.1097/00002030-200406003-00004.
Nieuwkerk, M. A., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response. A meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 38, 445–448. doi:10.1097/01.qai.0000147522.34369.12.
Olsson, I., Kykletun, A., & Dahl, A. (2005). The hospital anxiety and depression rating scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry, 5, 46. doi:10.1186/1471-244X-5-46.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.
Pence, B. W., Miller, W. C., Gaynes, B. N., & Eron, J. J. (2007). Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 44, 159–166. doi:10.1097/QAI.0b013e31802c2f51.
Pinheiro, C. A. T., De-Carvalho-Leite, J. C., Drachler, M. L., & Silveira, V. L. (2002). Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil. Brazilian Journal of Medical and Biological Research, 35, 1173–1181.
Rodrigues-Júnior, A. L., & Castilho, E. A. (2004). A epidemia de AIDS no Brasil, 1991–2000: descrição espaço-temporal. Revista da Sociedade Brasileira de Medicina Tropical, 37, 312–317.
Santos, F. R. M., Kozasa, E. H., Chauffaille, M. L. L. F., Colleoni, G. W. B., & Leite, J. R. (2006). Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. Journal of Psychosomatic Research, 60, 505–511. doi:10.1016/j.jpsychores.2005.08.017.
Simoni, J. M., Kurth, A. E., Pearson, C. R., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. doi:10.1007/s10461-006-9078-6.
Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., & Moatti, J. P. (2002). Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Social Science and Medicine, 54, 1481–1496. doi:10.1016/S0277-9536(01)00125-3.
Tostes, M. A., Chalub, M., & Botega, N. J. (2004). The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care, 16, 177–186. doi:10.1080/09540120410001641020.
Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of non-adherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114, 573–580. doi:10.1016/S0002-9343(03)00093-7.
Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral non-adherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 363–370. doi:10.1037/0278-6133.23.4.363.
Turner, B. J. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. The Journal of Infectious Diseases, 185, S143–S151. doi:10.1086/340197.
Wagner, G., & Miller, L. G. (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndrome, 35, 203–204. doi:10.1097/00126334-200402010-00016.
Wolf, M. S., Davis, T. C., Arozullah, A., Penn, R., Arnold, C., Sugar, M., et al. (2005). Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care, 17, 863–873.
World Health Organization. (2001). Adherence to long-term therapies: Policy for action. Geneva: World Health Organization.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 370–376. doi:10.1111/j.1600-0447.1983.tb09716.x.
Acknowledgements
This study was financed in the framework of the ATAR Project (Adherence Study Among Patients Initiating Antiretroviral Treatment), sponsored by the Pan-American Health Organization and the AIDS National Program of the Brazilian Ministry of Health (PN-DST/AIDS Brasil—UNESCO 914/BRA/3014) and was developed by the Research Group on Epidemiology and Health Services Evaluation (Grupo de Pesquisas em Epidemiologia e Avaliação em Saúde—GPEAS) from the Federal University of Minas Gerais, Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campos, L.N., Guimarães, M.D.C. & Remien, R.H. Anxiety and Depression Symptoms as Risk Factors for Non-adherence to Antiretroviral Therapy in Brazil. AIDS Behav 14, 289–299 (2010). https://doi.org/10.1007/s10461-008-9435-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-008-9435-8